Resources from the same session
655MO - Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy (RT) with either cisplatin or cetuximab in NRG/RTOG 1016
Presenter: Jolie Ringash
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
656MO - Phase I study of M6620 (VX-970, berzosertib) in combination with cisplatin and XRT in patients with locally advanced head and neck squamous cell carcinoma
Presenter: Aarti Bhatia
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
657MO - Effectiveness of geriatric assessment-driven interventions on quality of life for 2 years in older patients with head and neck cancer: Results from the EGeSOR trial
Presenter: Charlotte Lafont
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
658MO - Pembrolizumab (pembro) vs standard-of-care (SOC) in previously treated recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): 6-year follow-up of KEYNOTE-040
Presenter: Denis Soulieres
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
659MO - Pembrolizumab with or without chemotherapy for first-line treatment of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): 5-year results from KEYNOTE-048
Presenter: Makoto Tahara
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
LBA33 - 5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in a randomized, phase II study
Presenter: Jean Bourhis
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
Invited Discussant 658MO, 659MO and LBA33
Presenter: Ana Martins Ferreira Varges Gomes
Session: Mini Oral session: Head & neck cancer
Resources:
Slides
Webcast
660MO - Molecular targets in salivary gland cancers: A comprehensive genomic analysis of 1,666 cases
Presenter: Abirami Sivapiragasam
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
654MO - High dimensional immuno-phenotyping of immunotherapy response in head and neck cancer
Presenter: Kenneth O'Byrne
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
661MO - Evaluation of the DNA damage response (DDR) network as predictor of nivolumab efficacy in head and neck squamous cell carcinoma (HNSCC)
Presenter: Panagiota Economopoulou
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast